Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank93
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive growthStrong
Average
-1635.83%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-184.73%-102.1%
2023-91.39%+92.0%
2022-1143.04%+86.5%
2021-8449.54%-93.5%
2020-4366.18%-480.3%
2019-752.41%+17.1%
2018-907.78%-913.8%
2017111.55%+119.4%
2016-574.80%-